Bioxytran, Inc
BIXT
Revenue
20.31k
▲6.99k▲52.52%
3 Months ChangeAssets
159.01k
▲30.46k▲23.69%
3 Months ChangeLiabilities
1.24M
▲15.07k▲1.23%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 10-Q
ID: 0001493152-24-042763
2024-10-29
Form 8-K
ID: 0001493152-24-042741
2024-08-20
Form 8-K
ID: 0001493152-24-033314
2024-08-14
Form 10-Q
ID: 0001493152-24-032356
2024-07-17
Form 8-K
ID: 0001493152-24-028081
2024-07-05
Form 8-K
ID: 0001493152-24-026269
2024-05-09
Form 8-K
ID: 0001493152-24-018484
2024-04-19
Form 10-Q
ID: 0001493152-24-015358
2024-04-19
Form 8-K
ID: 0001493152-24-015344
2023-11-03
Form 10-Q
ID: 0001493152-23-039202